MARSHALL WACE, LLP - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 375 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$29,811,392
+340.9%
245,928
+316.5%
0.06%
+361.5%
Q2 2023$6,761,490
-72.6%
59,042
-67.1%
0.01%
-75.0%
Q1 2023$24,707,268
+2.5%
179,259
-3.6%
0.05%
-3.7%
Q4 2022$24,102,528
-46.9%
186,005
-63.1%
0.05%
-35.7%
Q4 2021$45,352,000
+14529.7%
503,638
+14938.5%
0.08%
+8300.0%
Q3 2021$310,000
-79.6%
3,349
-82.8%
0.00%
-85.7%
Q2 2021$1,517,000
-12.1%
19,519
-15.6%
0.01%
-12.5%
Q1 2021$1,725,000
-5.2%
23,136
-4.2%
0.01%
-42.9%
Q3 2019$1,819,000
+27.9%
24,153
+102.4%
0.01%
+100.0%
Q1 2019$1,422,000
+25.2%
11,934
+14.7%
0.01%
-41.7%
Q4 2018$1,136,000
+134.2%
10,406
+183.8%
0.01%
+71.4%
Q2 2018$485,000
-18.1%
3,667
-54.1%
0.01%
-72.0%
Q1 2018$592,000
+73.1%
7,988
+30.0%
0.02%
+78.6%
Q4 2017$342,000
-72.7%
6,143
-77.9%
0.01%
-75.9%
Q3 2017$1,252,000
-86.0%
27,813
-86.8%
0.06%
-9.4%
Q3 2016$8,961,000
+5874.0%
210,000
+1759.1%
0.06%
+3100.0%
Q1 2015$150,00011,2960.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Perceptive Advisors 2,878,979$69,182,0007.27%
Eventide Asset Management 259,100$6,226,0000.97%
GLADE BROOK CAPITAL PARTNERS LLC 251,000$6,032,0000.93%
IMS Capital Management 32,215$774,0000.91%
Perceptive Advisors 350,000$8,413,0000.88%
Benchmark Capital Advisors 34,900$839,0000.58%
BECK CAPITAL MANAGEMENT, LLC 24,744$636,0000.49%
SABBY MANAGEMENT, LLC 352,100$8,461,0000.47%
Hatteras Alternative Mutual Funds, LLC 39,404$947,0000.46%
Potomac Capital Management, Inc. 22,100$531,0000.45%
View complete list of SAREPTA THERAPEUTICS INC shareholders